ROLE OF ASHMARIHARGHANVATI IN TREATMENT OF ASHMARI (KIDNEY STONE)

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF ASHMARIHARGHANVATI IN MANAGEMENT OF ASHMARI WITH SPECIAL REFERENCE TO UROLITHIASIS

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037134

Enrollment

Registered

2021-10-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Tab- Ashmariharghan vati: Tab Ashmariharghan vati 500 Mg Twice a day Per oral route for 1 month with water Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Size of calculus less than 10mm or 10mm , bilateral and unilateral calculus will be included , multiple calculus, patients with mild and moderate hydronephrosis

Exclusion criteria

Exclusion criteria: Urinary calculus of size more than 10mm, impacted stone , pyelonephritis, patients having gross hydro nephrosis, patient requires surgical intervention, uncontrolled DM, HTN, HIV, Malignancy, CCF, IBD, TB, HBsAG , Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Symptoms reduce like pain,nausea, burning micturation , dysuriaTimepoint: In a 1 to 4 weeks	—

Secondary

Measure	Time frame
extraction of small calculus and reduction in numbers of calculus , reduce tendernessTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDR SHAILESH JAISWAL

PARUL INSTITUTE OF AYURVEDA

shailesh.skp61@gmail.com9978608907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026